| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130041044 Phase separated composite |
| 02/14/2013 | US20130041022 Glyceollins Suppress Androgen-Responsive Prostate Cancer |
| 02/14/2013 | US20130041016 Compositions and Methods for Preventing and Treating Cancer via Modulating UBE1L, ISG215 and/or UBP43 |
| 02/14/2013 | US20130041011 Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom |
| 02/14/2013 | US20130041010 Compositions and methods for the specific inhibition of gene expression by dsrna containing modified nucleotides |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040952 Influenza virus inhibitors that disrupt nucleoprotein trimerization |
| 02/14/2013 | US20130040946 Substituted imidazopyrimidines and triazolopyrimidines |
| 02/14/2013 | US20130040897 Glycosylation of proteins in host cells |
| 02/14/2013 | US20130040894 Inhibition or activation of serine/threonine ulk3 kinase activity |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/14/2013 | US20130040886 Peptides and Methods for Inhibiting G alpha Protein Signaling |
| 02/14/2013 | US20130040837 Aptamer cell compositions |
| 02/14/2013 | US20130040829 In vitro model of latent mycobacterial infection |
| 02/14/2013 | US20130040391 Method for manufacturing glycoproteins having human-type glycosylation |
| 02/14/2013 | US20130040390 Culture medium supplement and use thereof |
| 02/14/2013 | US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/14/2013 | US20130040388 Cytostatic drug composition |
| 02/14/2013 | US20130040387 Method for inducing differentiation of pluripotent stem cells into skeletal muscle or skeletal muscle progenitor cells |
| 02/14/2013 | US20130040386 Genetically modified human natural killer cell lines |
| 02/14/2013 | US20130040385 Hiv-1 latency model for high throughput screening |
| 02/14/2013 | US20130040367 Phosphotriesterase from agrobacterium radiobacter p230 |
| 02/14/2013 | US20130040358 Vial useable in tissue extraction procedures |
| 02/14/2013 | US20130040346 Cellobiohydrolase Variants and Polynucleotides Encoding Same |
| 02/14/2013 | US20130040335 Multi-scale wrinkles for functional alignment of stem cells and cardiac derivatives |
| 02/14/2013 | US20130040330 Method for differentiation induction in cultured stem cells |
| 02/14/2013 | US20130040317 Cell lines comprising endogenous taste receptors and their uses |
| 02/14/2013 | US20130040316 Cell lines comprising endogenous taste receptors and their uses |
| 02/14/2013 | US20130040315 Human and murine stem-cell lines: models of endothelial cell precursors |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130040304 Compositions and Methods for Engineering Cells |
| 02/14/2013 | US20130040281 Procurement of Placental Stem Cells |
| 02/14/2013 | US20130040039 Cucumber variety nun 55507 cup |
| 02/14/2013 | US20130039991 Elimination of N-Glycolylneuraminic Acid From Animal Products For Human Use |
| 02/14/2013 | US20130039966 Bone Semi-Permeable Device |
| 02/14/2013 | US20130039945 Anti-Viral Compounds |
| 02/14/2013 | US20130039944 Anti-Viral Compounds |
| 02/14/2013 | US20130039935 Induction of tumor immunity by variants of folate binding protein |
| 02/14/2013 | US20130039933 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039922 Antibodies that inhibit metalloproteins |
| 02/14/2013 | US20130039915 Siglec 15 antibodies in treating bone loss-related disease |
| 02/14/2013 | US20130039913 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 02/14/2013 | US20130039907 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/14/2013 | US20130039896 Pharmaceutical kits comprising mesenchymal stem cells |
| 02/14/2013 | US20130039894 Polypeptides and Use Thereof for Treatment of Traumatic or Degenerative Neuronal Injury |
| 02/14/2013 | US20130039893 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 02/14/2013 | US20130039891 Poxviral oncolytic vectors |
| 02/14/2013 | US20130039886 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity |
| 02/14/2013 | US20130039852 Methods of targeting cells for diagnosis and therapy |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | CA2844580A1 Stem cell therapy using inhibitors of lysophosphatidic acid |
| 02/14/2013 | CA2844106A1 Methods of treatment of retinal degeneration diseases |
| 02/14/2013 | CA2843837A1 Methods and compositions for improving sperm functionality |
| 02/14/2013 | CA2842821A1 Isolation and detection of cancer cells |
| 02/14/2013 | CA2841874A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/14/2013 | CA2841181A1 Novel anti-human ngf antibody |
| 02/14/2013 | CA2838486A1 Method of identifying agents that affect maturation, survival and myelination |
| 02/13/2013 | EP2557160A2 Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 02/13/2013 | EP2557157A1 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
| 02/13/2013 | EP2557154A2 Method for increasing activity in human stem cell |
| 02/13/2013 | EP2557153A2 Method for producing a neural matrix |
| 02/13/2013 | EP2557152A1 Key genes, micrornas, other non-coding rnas and combinations thereof for identifying and regulating pluripotency of cells |
| 02/13/2013 | EP2557089A2 Compositions and methods for immunomodulation |
| 02/13/2013 | EP2556747A2 Antibody producing non-human mammals. |
| 02/13/2013 | EP2556376A2 Secretome profile-facilitated in vitro fertilization |
| 02/13/2013 | EP2556149A1 Cell poration |
| 02/13/2013 | EP2556148A2 Method for the generation of monoclonal antibodies derived from human b cells |
| 02/13/2013 | EP2556147A1 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
| 02/13/2013 | EP2556146A2 Methods and systems for reducing dna fragmentation in a processed sperm sample |
| 02/13/2013 | EP2556145A1 Angiogenesis using placental stem cells |
| 02/13/2013 | EP2556144A1 Use of a proteolytic enzyme for the modification of the cell surface of a stem cell |
| 02/13/2013 | EP2556090A2 Soluble human st-2 antibodies and assays |
| 02/13/2013 | EP2556086A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 02/13/2013 | EP2556084A1 Cdca5 peptides and vaccines including the same |
| 02/13/2013 | EP2555782A1 Compositions and methods for providing hematopoietic function without hla matching |
| 02/13/2013 | EP2555781A1 Compositions and methods for providing hematopoietic function |
| 02/13/2013 | CN1520256B Use of follistatin to increase muscle mass |
| 02/13/2013 | CN102933709A A polynucleotide encoding ppat derived from jatropha and use thereof |
| 02/13/2013 | CN102933705A Decellularized adipose tissue |
| 02/13/2013 | CN102933704A Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
| 02/13/2013 | CN102933703A Angiogenesis using placental stem cells |
| 02/13/2013 | CN102933702A Methods of inducing tissue regeneration |
| 02/13/2013 | CN102933072A Barley and uses thereof |
| 02/13/2013 | CN102925479A 增强表达的内含子序列 Enhanced expression of intron sequences |
| 02/13/2013 | CN102925455A Plants having improved growth characteristics and a method for making the same |
| 02/13/2013 | CN102925427A Acrylyl lysine translation system and application thereof |
| 02/13/2013 | CN102925417A Glyphosate tolerance 5-enol pyruvoyl shikimic acid-3-phosphoric acid and coded sequence |
| 02/13/2013 | CN102925413A Hybridoma producing anti-t-PSA monoclonal antibody, and preparation method of t-PSA detection kit |
| 02/13/2013 | CN102925412A Method for preparing tumor specific antigen sensitized DC |
| 02/13/2013 | CN102925411A Application of vitamin C in in-vitro expansion of number of effector memory T cells |
| 02/13/2013 | CN102925410A Method for preparing CIK cell by using heparin anticoagulant plasma |
| 02/13/2013 | CN102925409A Extraction and multiplication culture method and application of urine mesenchymal stem cells |
| 02/13/2013 | CN102925408A Method for differentiating induced pluripotent stem (iPS) cells into cartilage cells |
| 02/13/2013 | CN102925407A In-vitro culture method of triploid loach fin cells |
| 02/13/2013 | CN102925406A Methods for identifying factors for differentiating definitive endoderm |